欧洲的生育保护实践和胃肠道瘤学家:一项泛欧洲研究
Irit Ben-Aharon1,2, Tal Goshen-Lago1, Alberto Puccini3,4
1Division of Oncology, Rambam Health Care Campus, Haifa 31096, Israel.
The oncologist
|November 8, 2025
概括
在欧洲的胃肠道 (GI) 瘤学家中,生育保存的讨论和实践在很大程度上存在差异. 许多瘤学家并不总是为年轻的胃肠道癌患者提供生育能力保护 (FP) 选择,这凸显了改善教育和标准化护理的需要.
科学领域:
- 在瘤学瘤学.
- 生殖医学 生殖医学
- 公共卫生 公共卫生
背景情况:
- 早期发病的胃肠道 (GI) 癌症的发病率不断上升,需要关注生育能力的保护 (FP).
- 与其他恶性瘤相比,在肠道癌症中对生育结果的数据有限.
- 目前欧洲在胃肠道瘤学家中FP的实践仍未得到评估.
研究的目的:
- 评估欧洲GI瘤学家当前的生育保护 (FP) 实践.
- 为了识别年轻的胃肠道癌症患者的FP讨论和转诊的变化.
主要方法:
- 在27个欧洲国家,向226名胃肠道瘤学家进行了横截面调查.
- 10项电子调查专注于共同生育实践和患者推.
- 基于国家,患者数量和瘤类型的统计分析.
主要成果:
- 57%的瘤学家与40岁以下的患者讨论生育问题;36%的患者只在治疗环境中讨论生育问题.
- 在男性 (精子保存) 和女性患者 (卵细胞/胚胎/卵巢冷保存,卵巢转移) 的FP转诊中观察到显著的异质性.
- 17%的瘤学家报告说,由于资源有限,他们没有将可治愈的患者转诊给FP.
结论:
- 对于年轻的胃肠道癌症患者的欧洲FP实践存在实质性的多样性,往往与指南不一致.
- 在胃肠道瘤学家中需要加强教育和传播瘤生育数据.
- 需要进一步的研究来确定FP选项在肠道癌症治疗中的有用性.
相关概念视频
Infertility in Males
519
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
519
Infertility in Females
3.6K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
3.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


